Spruce Biosciences (SPRB) EPS (Basic) (2022 - 2025)
Spruce Biosciences (SPRB) has disclosed EPS (Basic) for 4 consecutive years, with -$8.89 as the latest value for Q4 2025.
- On a quarterly basis, EPS (Basic) rose 79.19% to -$8.89 in Q4 2025 year-over-year; TTM through Dec 2025 was -$50.83, a 47.27% increase, with the full-year FY2025 number at -$50.83, up 47.27% from a year prior.
- EPS (Basic) was -$8.89 for Q4 2025 at Spruce Biosciences, up from -$14.58 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.23 in Q4 2023 to a low of -$42.71 in Q4 2024.
- A 4-year average of -$9.4 and a median of -$0.49 in 2022 define the central range for EPS (Basic).
- Peak YoY movement for EPS (Basic): tumbled 18469.57% in 2024, then skyrocketed 79.19% in 2025.
- Spruce Biosciences' EPS (Basic) stood at -$0.47 in 2022, then soared by 51.06% to -$0.23 in 2023, then tumbled by 18469.57% to -$42.71 in 2024, then surged by 79.19% to -$8.89 in 2025.
- Per Business Quant, the three most recent readings for SPRB's EPS (Basic) are -$8.89 (Q4 2025), -$14.58 (Q3 2025), and -$27.04 (Q2 2025).